LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹38 Cr | ₹57 Cr | ₹72 Cr | ₹130 Cr | ₹162 Cr |
What is the latest Total Debt ratio of LYKA LABS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹162 Cr |
How is Total Debt of LYKA LABS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | -32.99 | |
| Mar2024 | ₹57 Cr | -21.44 | |
| Mar2023 | ₹72 Cr | -44.54 | |
| Mar2022 | ₹130 Cr | -19.86 | |
| Mar2021 | ₹162 Cr | - | |
Compare Total Debt of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹215.2 Cr | 3.5% | -2.4% | -50.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 3.5% |
-2.4% |
-50.3% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses